Koninklijke Philips N.V. (ETR:PHI1)

Germany flag Germany · Delayed Price · Currency is EUR
22.76
-0.34 (-1.47%)
Aug 1, 2025, 5:35 PM CET

Verve Therapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
21,71122,79118,83412,09127,46238,828
Upgrade
Market Cap Growth
-12.07%21.01%55.77%-55.97%-29.27%2.18%
Upgrade
Enterprise Value
28,34229,27926,11618,86534,32443,859
Upgrade
Last Close Price
22.7623.4819.6412.5128.1937.46
Upgrade
PE Ratio
134.02---8.2732.71
Upgrade
PS Ratio
1.221.261.040.681.602.24
Upgrade
PB Ratio
2.091.891.560.911.903.26
Upgrade
P/TBV Ratio
----36.6226.24
Upgrade
P/FCF Ratio
-18.409.84-5.9318.02
Upgrade
P/OCF Ratio
-14.658.34-5.4614.71
Upgrade
EV/Sales Ratio
1.591.631.441.062.002.53
Upgrade
EV/EBITDA Ratio
15.9018.3723.1721.2723.4515.94
Upgrade
EV/EBIT Ratio
27.7931.1862.63-66.9126.03
Upgrade
EV/FCF Ratio
34.4823.6313.65-7.4120.35
Upgrade
Debt / Equity Ratio
0.810.630.640.620.480.58
Upgrade
Debt / EBITDA Ratio
4.634.255.799.254.772.52
Upgrade
Debt / FCF Ratio
10.256.174.02-1.513.22
Upgrade
Asset Turnover
0.640.620.610.580.590.63
Upgrade
Inventory Turnover
2.933.062.842.843.103.26
Upgrade
Quick Ratio
0.720.800.740.740.891.01
Upgrade
Current Ratio
1.261.231.201.291.391.45
Upgrade
Return on Equity (ROE)
1.50%-6.98%-3.58%-11.66%4.64%8.15%
Upgrade
Return on Assets (ROA)
2.37%2.01%0.87%-0.38%1.09%3.85%
Upgrade
Return on Capital (ROIC)
3.39%2.98%1.26%-0.54%1.59%5.71%
Upgrade
Return on Capital Employed (ROCE)
5.50%4.50%2.00%-2.20%8.40%
Upgrade
Earnings Yield
0.75%-3.08%-2.47%-13.30%12.09%3.06%
Upgrade
FCF Yield
3.79%5.44%10.16%-5.20%16.88%5.55%
Upgrade
Dividend Yield
3.74%3.62%--2.86%2.15%
Upgrade
Payout Ratio
182.10%---14.52%0.08%
Upgrade
Buyback Yield / Dilution
1.66%1.57%0.37%0.55%0.90%1.52%
Upgrade
Total Shareholder Return
5.39%5.19%0.37%0.55%3.76%3.67%
Upgrade
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.